Lutetium-177-edotreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177-edotreotide, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors [Phase 1]